Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Open-market sale Chief Executive Officer sold 9,798 shares at $52.80 ($517,334)
  2. 4 Open-market sale Chief Executive Officer sold 6,967 shares at $52.58 ($366,325)
  3. 4 Open-market sale General Counsel and Secretary sold 2,112 shares at $52.58 ($111,049)
  4. 4 Open-market buy Chief Medical Officer bought 1,508 shares at $32.96 ($49,704)
  5. 4 Planned sale Chief Financial Officer sold 34,972 shares at $60.19 ($2,104,965)
  6. 4 Planned sale Chief Executive Officer sold 90,000 shares at an average $57.40 ($5,166,298)
  7. 4 Planned sale Chief Financial Officer sold 29,700 shares at an average $60.16 ($1,786,636)
  8. 4 Planned sale Chief Financial Officer sold 10,000 shares at an average $55.95 ($559,549)
  9. 4 Gift Chief Executive Officer gave 30,000 shares (gift)
  10. 4 Open-market sale Chief Executive Officer sold 50,895 shares at $67.91 ($3,456,279)
  11. 4 Open-market sale Chief Executive Officer sold 4,242 shares at $66.60 ($282,517)
  12. 4 Open-market sale General Counsel and Secretary sold 1,076 shares at $66.60 ($71,662)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Gift Chief Executive Officer gave 6,000 shares (gift)
  18. 4 Open-market sale Chief Executive Officer sold 13,081 shares at $58.15 ($760,660)
  19. 4 Open-market buy Director bought 20,000 shares at $57.03 ($1,140,600)
  20. 4 Open-market buy Director bought 989,812 shares at $52.03 ($51,499,918)

Page 3 of 26 · 502 filings